136 related articles for article (PubMed ID: 39739)
41. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites.
Burch EA; Goldschmidt TJ
South Med J; 1983 Aug; 76(8):991-5. PubMed ID: 6879296
[TBL] [Abstract][Full Text] [Related]
42. Effects of gradual decrease and discontinuation of neuroleptics on clinical condition and tardive dyskinesia [proceedings].
Branchey MH; Branehey LB; Richardson MA
Psychopharmacol Bull; 1981 Jan; 17(1):118-20. PubMed ID: 7232639
[No Abstract] [Full Text] [Related]
43. Relation of plasma prolactin to clinical response in schizophrenic patients.
Gruen PG; Sachar EJ; Altman N; Langer G; Tabrizi MA; Halpern FS
Arch Gen Psychiatry; 1978 Oct; 35(10):1222-7. PubMed ID: 29592
[TBL] [Abstract][Full Text] [Related]
44. Does loxapine have "atypical" properties? Clinical evidence.
Glazer WM
J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
[TBL] [Abstract][Full Text] [Related]
45. Loxapine versus thioridazine in the treatment of organic psychosis.
Versiani M; da Silva JA; Mundim FD
J Int Med Res; 1980; 8(1):22-30. PubMed ID: 7358200
[TBL] [Abstract][Full Text] [Related]
46. Very high dose loxapine in refractory schizophrenic patients.
Lehmann CR; Ereshefsky L; Saklad SR; Mings TE
Am J Psychiatry; 1981 Sep; 138(9):1212-4. PubMed ID: 7270726
[TBL] [Abstract][Full Text] [Related]
47. [Dysphagia or dysphagias during neuroleptic medication?].
Chaumartin N; Monville M; Lachaux B
Encephale; 2012 Sep; 38(4):351-5. PubMed ID: 22980477
[TBL] [Abstract][Full Text] [Related]
48. Neuroleptic malignant syndrome associated with loxapine.
Ewert AL; Kloek J; Wells B; Phelps S
J Clin Psychiatry; 1983 Jan; 44(1):37-8. PubMed ID: 6822486
[No Abstract] [Full Text] [Related]
49. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
[No Abstract] [Full Text] [Related]
50. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
Pool D; Bloom W; Mielke DH; Roniger JJ; Gallant DM
Curr Ther Res Clin Exp; 1976 Jan; 19(1):99-104. PubMed ID: 812671
[No Abstract] [Full Text] [Related]
51. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neurotic anxiety.
Versiani M; Bueno JR; Mundim FD; da Silva JA; Rocha AV
Curr Ther Res Clin Exp; 1976 Nov; 20(5):701-15. PubMed ID: 825357
[No Abstract] [Full Text] [Related]
52. Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial.
Fruensgaard K; Wollenberg J; Hansen KM; Fensbo C; Sihm F
Curr Med Res Opin; 1978; 5(8):601-7. PubMed ID: 361345
[TBL] [Abstract][Full Text] [Related]
53. A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
Paprocki J; Barcala Peixoto MP; Andrade NM
Psychopharmacol Bull; 1976 Apr; 12(2):32-4. PubMed ID: 769026
[No Abstract] [Full Text] [Related]
54. Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?
Meltzer HY; Jayathilake K
J Clin Psychiatry; 1999; 60 Suppl 10():47-51. PubMed ID: 10340687
[TBL] [Abstract][Full Text] [Related]
55. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Gaffney GR; Tune LE
J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
[TBL] [Abstract][Full Text] [Related]
56. [Multidimensional diagnostics in pharmacopsychiatry/results of therapy with desmethyl-loxapine (author's transl)].
Bergener M; Escher HD; Linden KJ
Arzneimittelforschung; 1976 Feb; 26(2):290-9. PubMed ID: 820358
[TBL] [Abstract][Full Text] [Related]
57. Clinical and plasma level characteristics of intramuscular and oral loxapine.
Simpson GM; Cooper TB; Lee JH; Young MA
Psychopharmacology (Berl); 1978 Mar; 56(2):225-32. PubMed ID: 417377
[TBL] [Abstract][Full Text] [Related]
58. Loxapine: fifteen years' clinical experience.
DePaulo JR; Ayd FJ
Psychosomatics; 1982 Mar; 23(3):261-71. PubMed ID: 7041162
[No Abstract] [Full Text] [Related]
59. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
[No Abstract] [Full Text] [Related]
60. Clinical pharmacological trial of loxapine succinate.
J Clin Pharmacol J New Drugs; 1970; 10(3):175-81. PubMed ID: 4910276
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
